Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is as good as it gets
It's obvious that from what was said about the "new guy" at the shareholder meeting (M and A experience, Investment Banker type) the company was not leading us to Turley.

Pohl probably was unable to land his 1st pick due to the uncertainty of PTSC's position. One way to ruin a carefully groomed resume is to take a job at a co. with great promise, and then get T-boned at the first intersection if the Markman doesn't go right.

Timing was the enemy here.

Let's hope that J Ward gets it right
Share
New Message
Please login to post a reply